Published in Medical Devices and Surgical Technology Week, October 17th, 2004
In a recent study, scientists in Germany "investigated the effects of" FUS "on specific molecular signaling and cellular response in three closely related human Tk6 lymphoblast cell lines that differed only in their p53 status."
"The applied ultrasound parameters fell between the physical dose range, which is safely used in medical diagnostics (peak pressure <0.1 MPa) and that used for high-energy FUS thermal ablation therapy (peak pressure >10 MPa)," noted A. Abdollahi and coauthors at the German Cancer Research Center in Heidelberg. "Based on cDNA microarrays and protein...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week